News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Alexander C. Okwonna, PharmD

Articles by Alexander C. Okwonna, PharmD

Correspondence regarding, "Cost Effectiveness of Thromboprophylaxis With a Low-Molecular-Weight Heparin Versus Unfractionated Heparin in Acutely Ill Medical Inpatients"

ByAlexander C. Okwonna, PharmD,Sujit S. Sansgiry, PhD

March 1st 2005

Latest Updated Articles

$Correspondence regarding, "Cost Effectiveness of Thromboprophylaxis With a Low-Molecular-Weight Heparin Versus Unfractionated Heparin in Acutely Ill Medical Inpatients"$
Correspondence regarding, "Cost Effectiveness of Thromboprophylaxis With a Low-Molecular-Weight Heparin Versus Unfractionated Heparin in Acutely Ill Medical Inpatients"
Published: March 1st 2005 | Updated:

Trending on AJMC

Expiring ACA Subsidies and CMS Payment Models Raise Costs for Consumers and Employers

FDA Approves Gene Therapy Onasemnogene Abeparvovec for Broader SMA Population

FDA Approves Durvalumab With FLOT Chemotherapy for Resectable Gastric and Gastroesophageal Junction Cancer

RSV Vaccination Effective in Older Adults, but Protection Declines Over Time

Patients Face New Care Complexities as DTC Options Expand

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.